Showing results (311-320 of 401) with videos related to
Sort By:
Pageof 41
Frontiers in Oncology|May 27, 2022
No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care TherapySebastian Johannes Schober, Erika Hallmen, Florian Reßle, et al.Bone Marrow Transplantation|September 28, 2018
AlloHSCT in paediatric ALL and AML in complete remission: improvement over time impacted by accreditation?Shahrzad Bakhtiar, Emilia Salzmann-Manrique, Martin Hutter, et al.Journal of Hematology & Oncology|January 17, 2025
Multinational retrospective analysis of bridging therapy prior to chimeric antigen receptor t cells for relapsed/refractory acute lymphoblastic leukemia in children and young adultsMaike Breidenbach, Peter Bader, Andishe Attarbaschi, et al.Haematologica|February 15, 2024
Approaches for bridging therapy prior to chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic B-lineage leukemia in children and young adultsTobias Feuchtinger, Peter Bader, Marion Subklewe, et al.Nature Medicine|October 3, 2018
Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cellMarco Ruella, Jun Xu, David M Barrett, et al.Leukemia|April 26, 2022
CD19 CAR T-cells for pediatric relapsed acute lymphoblastic leukemia with active CNS involvement: a retrospective international studyElad Jacoby, Sara Ghorashian, Britta Vormoor, et al.Cancers|January 11, 2025
Long-Term Outcomes and Quality of Life of High-Risk Neuroblastoma Patients Treated with a Multimodal Treatment Including Anti-GD2 Immunotherapy: A Retrospective Cohort StudyTim Flaadt, Jonas Rehm, Thorsten Simon, et al.Frontiers in Oncology|June 5, 2013
Clinical grade purification and expansion of NK cell products for an optimized manufacturing protocolUlrike Koehl, Claudia Brehm, Sabine Huenecke, et al.Bone Marrow Transplantation|September 27, 2019
Autoimmune cytopenias (AIC) following allogeneic haematopoietic stem cell transplant for acquired aplastic anaemia: a joint study of the Autoimmune Diseases and Severe Aplastic Anaemia Working Parties (ADWP/SAAWP) of the European Society for Blood and Marrow Transplantation (EBMT)Paul D E Miller, John A Snowden, Regis Peffault De Latour, et al.Bone Marrow Transplantation|February 7, 2024
Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppressionBarbara Meissner, Peter Lang, Peter Bader, et al.Pageof 41